Sarcopenia in the elderly: Basic and clinical issues

Geriatrics and Gerontology International

Volumn 12, Issue 3, 2012, Pages 388-396

  Wang, Cuiying ^a   Bai, Li ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Geriatrics; Muscle; Sarcopenia

Indexed keywords

GHRELIN; GROWTH HORMONE; LEPTIN; MYOSTATIN; TESTOSTERONE; TIBOLONE; VITAMIN D;

CLINICAL FEATURE; DISEASE COURSE; FALLING; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; INFLAMMATION; MORTALITY; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL CAPACITY; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; WORLD HEALTH ORGANIZATION;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; PREVALENCE; SARCOPENIA;

EID: 84862677592     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2012.00851.x     Document Type: Review

References (90)

1. Centers for Disease Control and Prevention (CDC). Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep 2003; 52: 101-104, 106.
2. Tedla FM, Friedman EA. The trend toward geriatric nephrology. Prim Care 2008; 35: 515-530, vii.
3. Janssen I. The epidemiology of sarcopenia. Clin Geriatr Med 2011; 27: 355-363.
4. Nair KS. Age-related changes in muscle. Mayo Clin Proc 2000; 75 (Suppl): S14-S18.
5. Fielding RA, Vellas B, Evans WJ etal. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-256.
6. Stanton BR. The neurology of old age. Clin Med 2011; 11: 54-56.
7. Lexell J, Henriksson-Larsen K, Winblad B, Sjostrom M. Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve 1983; 6: 588-595.
8. Ferrucci L, Guralnik JM, Buchner D etal. Departures from linearity in the relationship between measures of muscular strength and physical performance of the lower extremities: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 1997; 52: M275-M285.
9. Cohn SH, Vartsky D, Yasumura S etal. Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol 1980; 239: E524-E530.
10. Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 1988; 84: 275-294.
11. Edstrom E, Altun M, Bergman E etal. Factors contributing to neuromuscular impairment and sarcopenia during aging. Physiol Behav 2007; 92: 129-135.
12. Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging 2008; 12: 452-456.
13. Cruz-Jentoft AJ, Baeyens JP, Bauer JM etal. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
14. Zadik Z, Chalew SA, McCarter RJ, Jr, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985; 60: 513-516.
15. Papadakis MA, Grady D, Black D etal. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996; 124: 708-716.
16. Guillet C, Prod'homme M, Balage M etal. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J 2004; 18: 1586-1587.
17. Lang CH, Frost RA, Nairn AC, MacLean DA, Vary TC. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 2002; 282: E336-E347.
18. Zoico E, Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr Rev 2002; 60: 39-51.
19. Biolo G, Declan Fleming RY, Wolfe RR. Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J Clin Invest 1995; 95: 811-819.
20. Carbo N, Ribas V, Busquets S, Alvarez B, Lopez-Soriano FJ, Argiles JM. Short-term effects of leptin on skeletal muscle protein metabolism in the rat. J Nutr Biochem 2000; 11: 431-435.
21. Walrand S, Guillet C, Salles J, Cano N, Boirie Y. Physiopathological mechanism of sarcopenia. Clin Geriatr Med 2011; 27: 365-385.
22. Short KR, Nair KS. The effect of age on protein metabolism. Curr Opin Clin Nutr Metab Care 2000; 3: 39-44.
23. Klitgaard H, Mantoni M, Schiaffino S etal. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand 1990; 140: 41-54.
24. Delmonico MJ, Harris TB, Lee JS etal. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007; 55: 769-774.
25. Goodpaster BH, Park SW, Harris TB etal. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61: 1059-1064.
26. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004; 159: 413-421.
27. Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci 2008; 63: 160-164.
28. Baumgartner RN, Koehler KM, Gallagher D etal. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
29. Zoico E, Di Francesco V, Guralnik JM etal. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord 2004; 28: 234-241.
30. Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci 2008; 63: 829-834.
31. Yang JG, Yin CH, Li CL, Zou LF. Simultaneously significant hepatic and mild splenic uptake of Tc-99m MDP resulting from Waldenstrom macroglobulinemia. Clin Nucl Med 2009; 34: 441-442.
32. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-896.
33. Norman K, Pirlich M, Sorensen J etal. Bioimpedance vector analysis as a measure of muscle function. Clin Nutr 2009; 28: 78-82.
34. Newman AB, Kupelian V, Visser M etal. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003; 51: 1602-1609.
35. Szulc P, Beck TJ, Marchand F, Delmas PD. Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men - the MINOS study. J Bone Miner Res 2005; 20: 721-729.
36. Miller MD, Crotty M, Giles LC etal. Corrected arm muscle area: an independent predictor of long-term mortality in community-dwelling older adults? J Am Geriatr Soc 2002; 50: 1272-1277.
37. Enoki H, Kuzuya M, Masuda Y etal. [Anthropometric measurements as a predictor of mortality of community-dwelling Japanese elderly: the Nagoya Longitudinal Study of Frail Elderly (NLS-FE)]. Nihon Ronen Igakkai Zasshi 2007; 44: 212-218.
38. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007; 86: 1339-1346.
39. Heitmann BL, Erikson H, Ellsinger BM, Mikkelsen KL, Larsson B. Mortality associated with body fat, fat-free mass and body mass index among 60-year-old swedish men-a 22-year follow-up. The study of men born in 1913. Int J Obes Relat Metab Disord 2000; 24: 33-37.
40. Morley JE, Argiles JM, Evans WJ etal. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010; 11: 391-396.
41. Perry HM, 3rd, Miller DK, Patrick P, Morley JE. Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. Metabolism 2000; 49: 1085-1091.
42. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 2001; 86: 4078-4088.
43. Weikert C, Pischon T, Weikert S. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 1865; author reply 66-67.
44. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981; 67: 1361-1369.
45. Taaffe DR, Pruitt L, Reim J etal. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994; 79: 1361-1366.
46. Thompson JL, Butterfield GE, Gylfadottir UK etal. Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab 1998; 83: 1477-1484.
47. Nagaya N, Uematsu M, Kojima M etal. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430-1435.
48. Garcia JM, Polvino WJ. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 2007; 12: 594-600.
49. Scarlett JM, Bowe DD, Zhu X, Batra AK, Grant WF, Marks DL. Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure. J Endocrinol 2010; 206: 121-130.
50. von Haehling S, Stepney R, Anker SD. Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference. Int J Cardiol 2010; 144: 347-349.
51. Jacobsen DE, Samson MM, Kezic S, Verhaar HJ. Postmenopausal HRT and tibolone in relation to muscle strength and body composition. Maturitas 2007; 58: 7-18.
52. Onder G, Della Vedova C, Landi F. Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia. J Nutr Health Aging 2009; 13: 746-756.
53. Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ. The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women. Endocrinology 2001; 142: 4813-4817.
54. Sahu A. Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 2004; 145: 2613-2620.
55. Sainz N, Rodriguez A, Catalan V etal. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS ONE 2009; 4: e6808.
56. Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 2008; 29: 361-368.
57. Braddy KK, Imam SN, Palla KR, Lee TA. Vitamin d deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis. J Am Med Dir Assoc 2009; 10: 653-657.
58. Artaza JN, Bhasin S, Magee TR etal. Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 2005; 146: 3547-3557.
59. Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 2009; 39: 283-296.
60. Rivas DA, Lessard SJ, Coffey VG. mTOR function in skeletal muscle: a focal point for overnutrition and exercise. Appl Physiol Nutr Metab 2009; 34: 807-816.
61. Hulmi JJ, Tannerstedt J, Selanne H, Kainulainen H, Kovanen V, Mero AA. Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men. J Appl Physiol 2009; 106: 1720-1729.
62. Kumar V, Selby A, Rankin D etal. Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J Physiol 2009; 587: 211-217.
63. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967; 242: 2278-2282.
64. Chow LS, Greenlund LJ, Asmann YW etal. Impact of endurance training on murine spontaneous activity, muscle mitochondrial DNA abundance, gene transcripts, and function. J Appl Physiol 2007; 102: 1078-1089.
65. McCully KK, Posner JD. The application of blood flow measurements to the study of aging muscle. J Gerontol A Biol Sci Med Sci 1995; 50 Spec No: 130-136.
66. Rogers MA, Evans WJ. Changes in skeletal muscle with aging: effects of exercise training. Exerc Sport Sci Rev 1993; 21: 65-102.
67. Ochi M, Kohara K, Tabara Y etal. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 2010; 212: 327-332.
68. Payne GW. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation 2006; 13: 343-352.
69. Pillard F, Laoudj-Chenivesse D, Carnac G etal. Physical activity and sarcopenia. Clin Geriatr Med 2011; 27: 449-470.
70. Buford TW, Cooke MB, Willoughby DS. Resistance exercise-induced changes of inflammatory gene expression within human skeletal muscle. Eur J Appl Physiol 2009; 107: 463-471.
71. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A 2009; 106: 20405-20410.
72. Degens H, Erskine RM, Morse CI. Disproportionate changes in skeletal muscle strength and size with resistance training and ageing. J Musculoskelet Neuronal Interact 2009; 9: 123-129.
73. Reeves ND, Narici MV, Maganaris CN. In vivo human muscle structure and function: adaptations to resistance training in old age. Exp Physiol 2004; 89: 675-689.
74. Suetta C, Andersen JL, Dalgas U etal. Resistance training induces qualitative changes in muscle morphology, muscle architecture, and muscle function in elderly postoperative patients. J Appl Physiol 2008; 105: 180-186.
75. Visser M, Newman AB, Nevitt MC etal. Reexamining the sarcopenia hypothesis. Muscle mass versus muscle strength. Health, Aging, and Body Composition Study Research Group. Ann N Y Acad Sci 2000; 904: 456-461.
76. D'Antona G, Pellegrino MA, Carlizzi CN, Bottinelli R. Deterioration of contractile properties of muscle fibres in elderly subjects is modulated by the level of physical activity. Eur J Appl Physiol 2007; 100: 603-611.
77. Lanza IR, Nair KS. Muscle mitochondrial changes with aging and exercise. Am J Clin Nutr 2009; 89: 467S-471S.
78. Sallis RE. Exercise is medicine and physicians need to prescribe it! Br J Sports Med 2009; 43: 3-4.
79. Pietrangelo T, Mancinelli R, Toniolo L etal. Effects of local vibrations on skeletal muscle trophism in elderly people: mechanical, cellular, and molecular events. Int J Mol Med 2009; 24: 503-512.
80. Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci 2010; 11: 1509-1526.
81. Hurley BF, Roth SM. Strength training in the elderly: effects on risk factors for age-related diseases. Sports Med 2000; 30: 249-268.
82. Borst SE. Interventions for sarcopenia and muscle weakness in older people. Age Ageing 2004; 33: 548-555.
83. Nelson ME, Rejeski WJ, Blair SN etal. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1435-1445.
84. Taaffe DR, Duret C, Wheeler S, Marcus R. Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults. J Am Geriatr Soc 1999; 47: 1208-1214.
85. Chin APMJ, van Uffelen JG, Riphagen I, van Mechelen W. The functional effects of physical exercise training in frail older people: a systematic review. Sports Med 2008; 38: 781-793.
86. Harber MP, Konopka AR, Douglass MD etal. Aerobic exercise training improves whole muscle and single myofiber size and function in older women. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1452-R1459.
87. Hunter GR, McCarthy JP, Bamman MM. Effects of resistance training on older adults. Sports Med 2004; 34: 329-348.
88. Lepretre PM, Vogel T, Brechat PH etal. Impact of short-term aerobic interval training on maximal exercise in sedentary aged subjects. Int J Clin Pract 2009; 63: 1472-1478.
89. Loenneke JP, Wilson GJ, Wilson JM. A mechanistic approach to blood flow occlusion. Int J Sports Med 2010; 31: 1-4.
90. Fry CS, Glynn EL, Drummond MJ etal. Blood flow restriction exercise stimulates mTORC1 signaling and muscle protein synthesis in older men. J Appl Physiol 2010; 108: 1199-1209.